OPKO Health, Inc. (NASDAQ:OPK – Free Report) – Zacks Research dropped their FY2024 earnings per share estimates for shares of OPKO Health in a note issued to investors on Monday, May 27th. Zacks Research analyst I. Bandyopadhyay now forecasts that the biotechnology company will earn ($0.38) per share for the year, down from their previous […]